Upvote
Downvote
Scientist I, in Vitro Pharmacology
Share Job
- Suggest Revision
- Capstan Therapeutics, Inc. is a privately held biotechnology company dedicated to advancing in vivo cell reprogramming.
- The core platform technology comprises proprietary targeted lipid nanoparticles (tLNPs) that are composed of LNPs conjugated with a recombinant protein binder, such as a monoclonal antibody.
- tLNPs are designed to deliver payloads, including mRNA or gene editing tools, capable of reprogramming specific cell types in vivo.
- The Scientist I, In Vitro Pharmacology will play a key role in the pre-clinical pharmacology and toxicology team conducting in vitro studies to support in vivo tLNP-CAR product candidate testing, optimization and development for various indications including autoimmunity, fibrosis or oncology
- Utilize multi-color flow cytometry to phenotype immune cells.
Active Job
Updated 6 days agoSimilar Job
Relevance
Active